DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $219,840 | -98.2% | 916 | -98.1% | 0.01% | -98.4% |
| Q1 2023 | $12,348,700 | +294.0% | 48,995 | +316.9% | 0.62% | +388.2% |
| Q4 2022 | $3,134,577 | +927.7% | 11,751 | +895.0% | 0.13% | +958.3% |
| Q3 2022 | $305,000 | -94.9% | 1,181 | -95.0% | 0.01% | -94.3% |
| Q2 2022 | $6,029,000 | +1673.2% | 23,783 | +1953.8% | 0.21% | +2244.4% |
| Q1 2022 | $340,000 | -10.1% | 1,158 | +0.7% | 0.01% | -18.2% |
| Q4 2021 | $378,000 | -2.8% | 1,150 | -10.0% | 0.01% | -47.6% |
| Q3 2021 | $389,000 | +517.5% | 1,278 | +441.5% | 0.02% | +600.0% |
| Q2 2021 | $63,000 | -23.2% | 236 | -59.9% | 0.00% | -50.0% |
| Q1 2020 | $82,000 | -74.5% | 589 | -74.0% | 0.01% | -64.7% |
| Q3 2019 | $322,000 | 0.0% | 2,265 | 0.0% | 0.02% | +13.3% |
| Q2 2019 | $322,000 | -20.3% | 2,265 | -43.8% | 0.02% | -16.7% |
| Q1 2019 | $404,000 | 0.0% | 4,031 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $404,000 | -8.0% | 4,031 | -0.1% | 0.02% | -28.0% |
| Q3 2018 | $439,000 | +2.8% | 4,036 | -7.0% | 0.02% | -44.4% |
| Q2 2018 | $427,000 | -51.0% | 4,341 | -51.2% | 0.04% | +650.0% |
| Q1 2018 | $871,000 | +49.4% | 8,894 | +41.6% | 0.01% | -82.9% |
| Q4 2017 | $583,000 | +29050.0% | 6,281 | +31305.0% | 0.04% | – |
| Q2 2017 | $2,000 | -97.8% | 20 | -98.1% | 0.00% | -100.0% |
| Q1 2017 | $90,000 | -3.2% | 1,050 | -11.8% | 0.01% | 0.0% |
| Q4 2016 | $93,000 | -1.1% | 1,190 | -0.8% | 0.01% | 0.0% |
| Q3 2016 | $94,000 | – | 1,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |